Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucile Regard

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|March 29, 2024
[COPD: diagnostic and severity assessment]Lucile Regard, Nicolas Roche
Presse Medicale (Paris, France : 1983)|November 11, 2025
Difficult-to-treat COPD: from concept to practiceLucile Regard, Nicolas Roche
American Journal of Respiratory and Critical Care Medicine|November 5, 2024
CFTR Modulators for the Treatment of COPD: The Jury Is Still Out!Lucile Regard, Pierre-Régis Burgel
American Journal of Respiratory and Critical Care Medicine|January 23, 2025
COPD Detection: Hurdles and StrugglesLucile Regard, Thierry Perez, Nicolas Roche
American Journal of Respiratory and Critical Care Medicine|July 21, 2023
The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary DiseaseLucile Regard, Nicolas Roche, Pierre-Régis Burgel
The European Respiratory Journal|May 19, 2018
Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?Clémence Martin, Lucile Regard, Pierre-Régis Burgel
Archivos De Bronconeumologia|March 21, 2022
Cystic Fibrosis in 2021: "The Times They Are A-Changin"Lucile Regard, Clémence Martin, Pierre-Régis Burgel
The European Respiratory Journal|February 9, 2023
Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or <i>vice versa</i>?Lucile Regard, Pierre-Régis Burgel, Nicolas Roche
Diagnostic and Interventional Imaging|June 29, 2021
COVID-19 after 18 months: Where do we stand?Guillaume Chassagnon, Lucile Regard, Philippe Soyer, et al.
Expert Review of Respiratory Medicine|November 27, 2018
Acute and chronic non-pulmonary complications in adults with cystic fibrosisLucile Regard, Clémence Martin, Guillaume Chassagnon, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|March 29, 2024
[COPD: diagnostic and severity assessment]Lucile Regard, Nicolas Roche
Presse Medicale (Paris, France : 1983)|November 11, 2025
Difficult-to-treat COPD: from concept to practiceLucile Regard, Nicolas Roche
American Journal of Respiratory and Critical Care Medicine|November 5, 2024
CFTR Modulators for the Treatment of COPD: The Jury Is Still Out!Lucile Regard, Pierre-Régis Burgel
American Journal of Respiratory and Critical Care Medicine|January 23, 2025
COPD Detection: Hurdles and StrugglesLucile Regard, Thierry Perez, Nicolas Roche
American Journal of Respiratory and Critical Care Medicine|July 21, 2023
The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary DiseaseLucile Regard, Nicolas Roche, Pierre-Régis Burgel
The European Respiratory Journal|May 19, 2018
Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?Clémence Martin, Lucile Regard, Pierre-Régis Burgel
Archivos De Bronconeumologia|March 21, 2022
Cystic Fibrosis in 2021: "The Times They Are A-Changin"Lucile Regard, Clémence Martin, Pierre-Régis Burgel
The European Respiratory Journal|February 9, 2023
Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or <i>vice versa</i>?Lucile Regard, Pierre-Régis Burgel, Nicolas Roche
Diagnostic and Interventional Imaging|June 29, 2021
COVID-19 after 18 months: Where do we stand?Guillaume Chassagnon, Lucile Regard, Philippe Soyer, et al.
Expert Review of Respiratory Medicine|November 27, 2018
Acute and chronic non-pulmonary complications in adults with cystic fibrosisLucile Regard, Clémence Martin, Guillaume Chassagnon, et al.
Pageof 4